MindBio Therapeutics Corp. (CSE:MBIO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0250
0.00 (0.00%)
Feb 21, 2025, 4:00 PM EST
-61.54%
Market Cap 3.57M
Revenue (ttm) -175.79K
Net Income (ttm) -545.75K
Shares Out 142.96M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 28,310
Open 0.0250
Previous Close 0.0250
Day's Range 0.0250 - 0.0250
52-Week Range 0.0150 - 0.0750
Beta n/a
RSI 53.71
Earnings Date May 13, 2025

About MindBio Therapeutics

MindBio Therapeutics Corp., together with its subsidiaries, operates as a clinical stage drug development company in Australasia. The company engages in researching, developing, and testing microdosing of psychedelic substances as a potential treatment for the management of various mental health conditions, such as depression, anxiety, chronic pain, cognitive impairment, post-traumatic stress disorder, panic disorder, and opiate addictions. It also establishes and executes research protocols through formal clinical trials that are facilitated v... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol MBIO
Full Company Profile

Financial Performance

Financial numbers in AUD Financial Statements

News

There is no news available yet.